114
Views
0
CrossRef citations to date
0
Altmetric
Acute Pain and Perioperative Care

Efficacy and Safety of Ketamine Compared with Placebo and Other Medications for Preventing Propofol Injection Pain in Adults: A Systematic Review and Meta-Analysis

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 459-476 | Received 05 Oct 2023, Accepted 19 Jan 2024, Published online: 02 Feb 2024

Figures & data

Figure 1 The flow diagram of the selection process.

Figure 1 The flow diagram of the selection process.

Table 1 Characteristics of Included RCTs

Figure 2 The risk of bias of the included studies; (a) risk of bias for each study; (b) risk of bias summary.

Figure 2 The risk of bias of the included studies; (a) risk of bias for each study; (b) risk of bias summary.

Figure 3 The incidence of propofol injection pain in the ketamine group compared with the saline group.

Figure 3 The incidence of propofol injection pain in the ketamine group compared with the saline group.

Figure 4 The incidence of propofol injection pain in the ketamine group compared with the lidocaine group.

Figure 4 The incidence of propofol injection pain in the ketamine group compared with the lidocaine group.

Figure 5 The incidence of propofol injection pain in the ketamine group compared with the dexmedetomidine group.

Figure 5 The incidence of propofol injection pain in the ketamine group compared with the dexmedetomidine group.

Figure 6 The incidence of propofol injection pain in the ketamine group compared with the thiopental group.

Figure 6 The incidence of propofol injection pain in the ketamine group compared with the thiopental group.

Figure 7 The incidence of propofol injection pain in the separate injection group compared with the mixed injection group.

Figure 7 The incidence of propofol injection pain in the separate injection group compared with the mixed injection group.

Figure 8 The incidence of severe propofol injection pain in the ketamine group compared with the saline group.

Figure 8 The incidence of severe propofol injection pain in the ketamine group compared with the saline group.

Figure 9 The incidence of severe propofol injection pain in the ketamine group compared with the lidocaine group.

Figure 9 The incidence of severe propofol injection pain in the ketamine group compared with the lidocaine group.

Figure 10 The incidence of severe propofol injection pain in the ketamine group compared with the dexmedetomidine group.

Figure 10 The incidence of severe propofol injection pain in the ketamine group compared with the dexmedetomidine group.

Figure 11 The incidence of severe propofol injection pain in the ketamine group compared with the thiopental group.

Figure 11 The incidence of severe propofol injection pain in the ketamine group compared with the thiopental group.

Figure 12 The incidence of severe propofol injection pain in the separate injection group compared with the mixed injection group.

Figure 12 The incidence of severe propofol injection pain in the separate injection group compared with the mixed injection group.

Figure 13 Sensitivity analysis for meta-analysis comparing the incidence of PIP in the ketamine group and the saline group.

Figure 13 Sensitivity analysis for meta-analysis comparing the incidence of PIP in the ketamine group and the saline group.

Figure 14 Sensitivity analysis for meta-analysis comparing the incidence of PIP in the ketamine group and the lidocaine group.

Figure 14 Sensitivity analysis for meta-analysis comparing the incidence of PIP in the ketamine group and the lidocaine group.

Table 2 Results of Egger Tests and Trim-and-Fill Procedure

Figure 15 The funnel plot for the meta-analysis 1.1 processed by the trim-and-fill method.

Figure 15 The funnel plot for the meta-analysis 1.1 processed by the trim-and-fill method.

Figure 16 The funnel plot for the meta-analysis 2.1 processed by the trim-and-fill method.

Figure 16 The funnel plot for the meta-analysis 2.1 processed by the trim-and-fill method.